Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: EVELIQURE BIOTECHNOLOGIES GMBH
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-09-01 to 2027-03-31
Current total value of award: $10761648.3
Description: TO ADVANCE THE DEVELOPMENT OF THE SHIGETEC VACCINE THROUGH CGMP MANUFACTURING AND RELEASE OF ADDITIONAL CGMP LOTS FOR USE IN A SERIES OF PHASE 2 CLINICAL TRIALS.